Expanding in HMOs
30 Nov 2018 | Jennewein Biotechnologie
At HiE 2018 in Frankfurt, NutritionInsight spoke with Christian Metzmacher of Jennewein Biotechnologie about the company's most recent work with human milk oligosaccharides (HMOs). “We invented a specific fermentation process to produce these HMOs. As it turned out, there's a huge demand so we increased our production capacities by about 300 percent in the past 18 months,” he says, adding that this demand is driven by a desire to bridge the gap between breastmilk and infant formula.
